Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Natera Inc (NTRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8025
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Partnerships 15
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Equity Offering 18
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc – Key Competitors 22
Natera Inc – Key Employees 23
Natera Inc – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Strategy And Business Planning 25
Jan 04, 2017: Leading Genetic Testing Companies Join Forces to Launch the Coalition for Access to Prenatal Screening 25
Financial Announcements 26
Aug 08, 2018: Natera reports second quarter 2018 financial results 26
May 08, 2018: Natera Reports First Quarter 2018 Financial Results 28
Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 30
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 32
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 36
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 38
Corporate Communications 40
Jul 31, 2018: Natera appoints Roy Baynes to Board of Directors adding deep oncology experience 40
Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 41
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 42
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Natera Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9
Natera Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Natera Raises USD55.5 Million in Venture Financing 11
Natera Raises US$54.6 Million In Venture Financing 13
Natera Enters into Research Agreement with Neon Therapeutics 15
Natera Enters into Agreement with Imperial College London and University of Leicester 16
Natera Enters into Research Agreement with University of California, San Francisco 17
Natera Prices Public Offering of Shares for USD90 Million 18
Natera Raises USD180 Million in IPO 20
Natera Inc, Key Competitors 22
Natera Inc, Key Employees 23
Natera Inc, Subsidiaries 24

List of Figures
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Natera Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Natera Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Natera Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Natera Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Natera Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Natera Inc (NTRA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Terumo Corp (4543):企業の製品パイプライン分析2018
    Summary Terumo Corp (Terumo) is a medical technology company, which manufactures and sells a wide range of medical care products including hospital and medical products, and equipment. Its major product categories include vascular interventional products, cardiovascular surgical systems, artificial …
  • Integrated Silicon Solution, Inc.:企業の戦略的SWOT分析
    Integrated Silicon Solution, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Capital Lease Aviation Limited
    Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Capital Lease Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Metro AG:企業の戦略・SWOT・財務情報
    Metro AG - Strategy, SWOT and Corporate Finance Report Summary Metro AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • The J.M. Smucker Co:企業の戦略・SWOT・財務情報
    The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report Summary The J.M. Smucker Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bloomberg L.P.:企業の戦略・SWOT・財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務分析
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Cosumar SA:企業の戦略・SWOT・財務分析
    Cosumar SA - Strategy, SWOT and Corporate Finance Report Summary Cosumar SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Flex Ltd (FLEX):企業の財務・戦略的SWOT分析
    Flex Ltd (FLEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Dixie Group Inc:企業の戦略・SWOT・財務情報
    The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Healthsense Inc:医療機器:M&Aディール及び事業提携情報
    Summary Healthsense Inc (Healthsense), a subsidiary of GreatCall Inc is a medical device company that provides remote monitoring services. The company offers technology-enabled care solutions, aging technology services, for the entire senior care continuum. Its products include eNeighbor remote moni …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析
    Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • FMT Aircraft Gate Support Systems AB:企業の戦略・SWOT・財務情報
    FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report Summary FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Bonus BioGroup Ltd (BONS):医療機器:M&Aディール及び事業提携情報
    Summary Bonus BioGroup Ltd (Bonus BioGroup), formerly Oceania advanced industries Ltd is a biotechnology company that supplies tissue-engineered viable bone grafts. The company operates in the field of tissue engineering and live bone transplantation. Its products include BonoFill injectable bone gr …
  • Bombardier Inc:企業の戦略・SWOT・財務情報
    Bombardier Inc - Strategy, SWOT and Corporate Finance Report Summary Bombardier Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Belk Inc:企業の戦略・SWOT・財務分析
    Belk Inc - Strategy, SWOT and Corporate Finance Report Summary Belk Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Hon Hai Precision Industry Co., Ltd.:企業の戦略・SWOT・財務情報
    Hon Hai Precision Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hon Hai Precision Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Qatar National Bank (QNBK):企業の財務・戦略的SWOT分析
    Qatar National Bank (QNBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Orano SA:電力:M&Aディール及び事業提携情報
    Summary Orano SA (Orano), formerly New AREVA Holding, is an integrated nuclear energy company that transforms nuclear materials and provides technological solutions for power generation and allied services. It offers complete range of products and services that covers the entire nuclear fuel cycle r …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆